Top Dog Pet Store
TINA.org finds that this pet company’s health claims are all bark and no bite.
Combivent Respimat Asthma Inhalers
In May 2019, a class-action lawsuit was filed against Boehringer Ingelheim Pharmaceuticals for allegedly deceptively marketing that the Combivent Respimat asthma inhaler will provide 120 doses when, according to plaintiffs, the inhaler contains far fewer dosages, sometimes less than half the advertised amount. (Ignacuinos et al v. Boehringer Ingelheim Pharmaceuticals, Inc., Case No. 19-cv-672, D. Conn.)
The Latest
Rapid Radios
Does this walkie-talkie actually work from anywhere?
We Play Different | The North Face
Mother Nature doesn’t play games, and neither does The North Face
NA-KD Fashion
Not all free shipping claims are cut from the same cloth.
BullyKamp
FDA warns that this pet company’s marketing bites off more than it can chew.